BAM
BCRX icon

Belpointe Asset Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Belpointe Asset Management’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-500
Closed -$5.74K – 3735
2022
Q4 		$5.74K Buy
+500
New +$5.74K ﹤0.01% 2878